Hone adds IV and peptide services

The ivee deal pushes Hone beyond being a website that writes recurring prescriptions, into a care model with nurses, home blood draws, IV drips, and injectable add ons that are harder to copy and easier to mark up. That matters because Hone already runs on high monthly spend, around $225 per customer, and strong retention from ongoing hormone monitoring, so adding physical services gives it more ways to raise revenue per member without relying only on commodity mail order drugs.

• Hone started with a $129 to $149 membership plus paid add ons like testosterone and anastrozole. ivee adds in home phlebotomy, IV therapy, and nursing in 20 major metros, which extends the same subscription relationship into higher ticket procedures performed in the home.
  1 sacra 2 sacra 4 businesswire 5 sacra
• The clearest contrast is Hims and Ro. Their core model has been high volume, purely virtual prescribing across categories like ED, hair loss, and GLP-1s. Hone’s hormone business already requires regular labs and dose changes, and physical services make that gap even wider. Hims is only now moving deeper into testosterone through a Marius partnership launching in 2026.
  2 sacra 3 sacra 6 hims 7 globenewswire
• There is also a second lane of competition from longevity testing platforms like Function Health. Function sells lab subscriptions and imaging, but stays away from treatment management. Hone is doing the opposite, using diagnostics plus prescriptions plus in home services to capture more of the spend after a patient decides to act.
  2 sacra 8 sacra 9 cnbc

The next step is a fuller premium care stack, where Hone uses telehealth to acquire the customer, recurring labs to keep them engaged, and in home services to lift margin and expand categories from testosterone into menopause, weight loss, peptides, and longevity. That would move Hone closer to a concierge style health platform than a prescription checkout flow.